The immunophenotype of the predominantly mature, malignant T cells in these secondary lymphomas has varied across reported cases, encompassing CD4+ [5, 9, 15] and CD8+ variants [8, 11] as well as CD4-CD8- manifestations [10, 12, 13]. The gene discussed is CD4; the disease is lymphoma.